Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiovascular Effects of Adderall in Healthy Adults
NCT02979327Phase 4Completed
- Sponsor
- Mayo Clinic
- Start
- Jun 2018
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dextroamphetamine + amphetamine in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Mayo Clinic. Primary endpoints: Systolic Blood Pressure at 3 hours, Diastolic Blood Pressure at 3 hours and 2 more. Started Jun 2018; status: completed.
02
Drugs
dextroamphetamine + amphetamine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT02979327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02979327.